Minerva Surgical Valuation
| UTRSDelisted Stock | USD 0.26 0.00 0.00% |
Minerva Surgical seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Minerva Surgical from analyzing the firm fundamentals such as Profit Margin of (0.65) %, return on equity of -1.6, and Current Valuation of 42.81 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Minerva Surgical's price fluctuation is very steady at this time. Calculation of the real value of Minerva Surgical is based on 3 months time horizon. Increasing Minerva Surgical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Minerva pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Minerva Surgical. Since Minerva Surgical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Minerva Pink Sheet. However, Minerva Surgical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.26 | Real 0.22 | Hype 0.26 | Naive 0.28 |
The intrinsic value of Minerva Surgical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Minerva Surgical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Minerva Surgical helps investors to forecast how Minerva pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Minerva Surgical more accurately as focusing exclusively on Minerva Surgical's fundamentals will not take into account other important factors: Minerva Surgical Total Value Analysis
Minerva Surgical is at this time projected to have valuation of 42.81 M with market capitalization of 13.14 M, debt of 39.69 M, and cash on hands of 22.39 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Minerva Surgical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.81 M | 13.14 M | 39.69 M | 22.39 M |
Minerva Surgical Investor Information
About 90.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.51. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Minerva Surgical recorded a loss per share of 7.61. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of October 2023. Based on the analysis of Minerva Surgical's profitability, liquidity, and operating efficiency, Minerva Surgical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Minerva Surgical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Minerva Surgical has an asset utilization ratio of 73.0 percent. This implies that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Minerva Surgical is more efficient with each dollar of assets it utilizes for everyday operations.Minerva Surgical Ownership Allocation
The market capitalization of Minerva Surgical is $13.14 Million. The majority of Minerva Surgical outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Minerva Surgical to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Minerva Surgical. Please pay attention to any change in the institutional holdings of Minerva Surgical as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Minerva Surgical Profitability Analysis
The company reported the previous year's revenue of 50.29 M. Net Loss for the year was (34.11 M) with profit before overhead, payroll, taxes, and interest of 27.24 M.About Minerva Surgical Valuation
The pink sheet valuation mechanism determines Minerva Surgical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Minerva Surgical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Minerva Surgical. We calculate exposure to Minerva Surgical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Minerva Surgical's related companies.Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Minerva Surgical operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 157 people.
8 Steps to conduct Minerva Surgical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Minerva Surgical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Minerva Surgical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Minerva Surgical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Minerva Surgical's revenue streams: Identify Minerva Surgical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Minerva Surgical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Minerva Surgical's growth potential: Evaluate Minerva Surgical's management, business model, and growth potential.
- Determine Minerva Surgical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Minerva Surgical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Minerva Surgical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Minerva Surgical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.4 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Minerva Pink Sheet
If you are still planning to invest in Minerva Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Minerva Surgical's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |